webinar register page

Webinar banner
Incubator/Accelerator/Equity - Clinical Trial Management and Wellness Care
An innovator’s connection to a leadership accelerator, incubator or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities or build a go-to marketing plan? Beyond access to cash, what makes the innovator’s connection to an accelerator, incubator or private equity group success critical?

Oct 25, 2022 03:30 PM in Eastern Time (US and Canada)

Webinar logo
* Required information
Loading

Speakers

KittyHawk Ventures
MATTER Startup Incubation
Melissa Lederer
Chief Experience Officer @mHUB
Melissa Lederer, chief experience officer, is focused on leading teams to design solutions that drive engagement, collaboration, and success for mHUB corporate partners and startups. A seasoned business professional with more than 20 years of broad experience, Melissa has served a variety of technology-based businesses of all sizes and has a passion for supporting high-growth startups on brand formation and scaling into new markets. Over the past 10 years, Melissa has been an active force in building Chicago’s robust entrepreneurial community. Melissa was a member of the founding team of 1871, Chicago’s innovation hub recognized by UBI Global as the #1 university-affiliated incubator in the world and served as its chief marketing officer. Following 1871, Melissa helped found Chicago’s healthcare incubator and innovation center MATTER, where she was responsible for defining and building the MATTER brand and managing all areas of the company’s marketing, communications and events.
Novartis Biome
Wilfred Njagi
CEO @Villgro Africa
Ramita Tandon
Chief Clinical Trials Officer @Walgreens
As the Chief Clinical Trials Officer at Walgreens, Ramita Tandon is responsible for leading and driving growth for the Company’s new clinical trials business. In her role, Ramita works across the healthcare and life sciences industries to enable next-generation clinical trials so that breakthrough treatments reach patients faster. Ramita brings more than 25 years of leadership and operational experience across a portfolio of industry-leading businesses and services in real-world evidence and patient-centered health outcomes. Prior to joining Walgreens, she served as the Chief Operating Officer at Trio Health, and prior to that she was the Executive Vice President, Commercialization and Outcomes at ICON. Ramita is an internationally recognized speaker and author whose focus is on how to bridge the gap between commercial and clinical development. She is a graduate of the University of Michigan and the Boston University School of Public Health.
Ron Cohen, MD
President, CEO and founder @Acorda Therapeutics, Inc.,
Acorda Therapeutics, Inc., a public biotechnology company developing therapies for disorders of the nervous system, including already approved and commercialized therapies for Parkinson’s disease and Multiple Sclerosis. Dr. Cohen previously was a principal in the startup and an officer of Advanced Tissue Sciences, Inc., a biotechnology company engaged in the growth of human organ tissues for transplantation uses. He served as Chair of the Board of the Biotechnology Innovation Organization (BIO) and continues to serve as a Director. He has served on the Boards of several biotechnology companies, including VBL Therapeutics and Dyax Corp. until its acquisition in 2016. He also previously served as Chair of the Emerging Companies Section of the BIO Board and as Director and Chair of the New York Biotechnology Association (NYBA).